SCHEMBL292299

SCHEMBL292299

O=C1C[C@@H](c2ccc(O)c(O)c2)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc(O)c21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLCO2B1 O94956 3/20 1.00
▸ SYNJ2 O15056 1/20 1.00
▸ PTPN1 P18031 3/20 0.86
▸ KDM1A O60341 2/20 0.82
▸ PKM P14618 2/20 0.79
▸ DPP4 P27487 1/20 0.76
▸ GSK3B P49841 2/20 0.69
▸ CYP19A1 P11511 2/20 0.69
▸ UBE2N P61088 1/20 0.69
▸ POLB P06746 2/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ CALM1 P0DP23 1/20 0.64
▸ CACNA1B Q00975 1/20 0.64
▸ APBA1 Q02410 1/20 0.64
▸ CTDSP1 Q9GZU7 1/20 0.64
▸ TRPA1 O75762 1/20 0.63
▸ P4HB P07237 1/20 0.63
▸ TRPV1 Q8NER1 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20437868 1.00 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
SCHEMBL3451231 1.00 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
SCHEMBL28281120 1.00 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
SCHEMBL29559106 1.00 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
SCHEMBL3934884 1.00 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
Prunin SCHEMBL1122487 0.93 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
Prunin SCHEMBL2532187 0.93 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
Prunin SCHEMBL31233345 0.93 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
Prunin SCHEMBL318230 0.93 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM
Prunin SCHEMBL31233342 0.93 SLCO2B1 (1.00) SLCO2B1SYNJ2PTPN1KDM1APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446319-B2 Composition containing flavonoid-cyclodextrin clathrate compound TAIYO KAGAKU CO., LTD. (JP) 2022-09-20 — — US claimed
EP-3805399-A1 COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND Taiyo Kagaku Co., Ltd. (JP) 2021-04-14 — — EP claimed
CN-112236525-A Compositions containing flavonoid-cyclodextrin inclusion compounds 太阳化学株式会社 2021-01-15 — — CN claimed
US-5952391-A STABILIZING COSMETIC OR DERMATOLOGILICAL FORMULATIONS BEIERSDORF AG (DE) 1999-09-14 — — US claimed
EP-0317453-B1 MEDICINAL COMPOSITIONS BASED ON FLAVONOIDS AND SAPONINS EXTRACTED FROM CHRYSANTHELLUM, PROCESS FOR THEIR MANUFACTURE AND THERAPEUTICAL USES IPHYM SA Société Anonyme dite : (FR) 1993-02-03 — — EP claimed
JP-8073337-A — — None — — JP disclosed
US-20230270148-A1 BITTER BLOCKERS AND RELATED METHODS OF USE CONAGEN INC. (US) 2023-08-31 — — US disclosed
US-20230270148-A1 BITTER BLOCKERS AND RELATED METHODS OF USE CONAGEN INC. (US) 2023-08-31 — — US disclosed
US-11446319-B2 Composition containing flavonoid-cyclodextrin clathrate compound TAIYO KAGAKU CO., LTD. (JP) 2022-09-20 — — US disclosed
US-20210205344-A1 COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND TAIYO KAGAKU CO., LTD. (JP) 2021-07-08 — — US disclosed
EP-3805399-A1 COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND Taiyo Kagaku Co., Ltd. (JP) 2021-04-14 — — EP disclosed
CN-112236525-A Compositions containing flavonoid-cyclodextrin inclusion compounds 太阳化学株式会社 2021-01-15 — — CN disclosed
US-20030118621-A1 Cosmetic and dermatological preparations in stick form, comprising an amino-substituted hydroxybenzophenone BASF AKTIENGESELLSCHAFT (DE) 2003-06-26 — — US disclosed
CN-1406578-A Cosmetic O/W emulsion and agents for skin containing amino sustituted hydroxy diphenyl ketone BASF AG (DE) 2003-04-02 — — CN disclosed
CN-1406574-A Cosmetic stick and prepared agents for skin containing amino substituted hydroxy diphenyl ketone BASF AG (DE) 2003-04-02 — — CN disclosed
US-20020182234-A1 Self-foaming or foam-like preparations BEIERSDORF AKTIENGESELLSCHAFT 2002-12-05 — — US disclosed
US-20020102289-A1 Cosmetic or dermatological impregnated wipes BEIERSDORF AG (DE) 2002-08-01 — — US disclosed
US-20020013481-A1 USE OF FLAVONES FLAVANONES AND FLAVONOIDS FOR PROTECTING ASCORBIC ACID AND/OR ASCORBYL COMPOUNDS FROM OXIDATION BEIERSDORF AG (DE) 2002-01-31 — — US disclosed
US-5952391-A STABILIZING COSMETIC OR DERMATOLOGILICAL FORMULATIONS BEIERSDORF AG (DE) 1999-09-14 — — US disclosed
JP-H0873337-A EXTERNAL PREPARATION COMPOSITION OGAWA KORYO KK 1996-03-19 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118621-A1 Cosmetic and dermatological preparations in stick form, comprising an amino-substituted hydroxybenzophenone CUTA, TYR, FABP4 SLCO2B1 433/4885SYNJ2 2518/4885PTPN1 1008/4885
US-20020182234-A1 Self-foaming or foam-like preparations FFAR2, LIPA, FFAR1 SLCO2B1 1040/4885SYNJ2 1157/4885PTPN1 3530/4885
US-20020102289-A1 Cosmetic or dermatological impregnated wipes CUTA, PWWP2B, WIZ SLCO2B1 4529/4885SYNJ2 124/4885PTPN1 739/4885
US-20230270148-A1 BITTER BLOCKERS AND RELATED METHODS OF USE TAS2R5, TAS2R40, TAS2R30 SLCO2B1 711/4885SYNJ2 3987/4885PTPN1 2641/4885
US-20020013481-A1 USE OF FLAVONES FLAVANONES AND FLAVONOIDS FOR PROTECTING ASCORBIC ACID AND/OR ASCORBYL COMPOUNDS FROM OXIDATION TTPA, PROC, SOD1 SLCO2B1 1678/4885SYNJ2 985/4885PTPN1 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback